| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/29/2014 | CA2724533C Stabilized atypical antipsychotic formulation |
| 07/29/2014 | CA2662510C Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy |
| 07/29/2014 | CA2652500C Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 07/29/2014 | CA2644429C Bioresorbable controlled-release composition |
| 07/29/2014 | CA2611724C Stabilized milnacipran formulation |
| 07/29/2014 | CA2592249C Binding proteins specific for human matriptase |
| 07/29/2014 | CA2547043C A plasma source and applications thereof |
| 07/29/2014 | CA2540539C A mixture for transdermal delivery of low and high molecular weight compounds comprising an ethoxylated oil |
| 07/29/2014 | CA2494974C Il-7 drug substance, composition, preparation and uses |
| 07/29/2014 | CA2486104C Tri-block polymers for nanosphere-based drug or gene delivery |
| 07/29/2014 | CA2483451C Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance |
| 07/29/2014 | CA2449713C Calcium phosphate delivery vehicles for osteoinductive proteins |
| 07/24/2014 | WO2014113638A1 Multi-use albuterol maintenance therapy formulations and devices therefor |
| 07/24/2014 | WO2014113260A1 Androgen receptor modulator and uses thereof |
| 07/24/2014 | WO2014111737A1 Composition for increasing of the effectiveness of uv-b therapy, process for the preparation thereof, and its use |
| 07/24/2014 | WO2014111724A1 Glycosylation method |
| 07/24/2014 | WO2014111344A1 Cycloalkyne derivatized saccharides |
| 07/24/2014 | WO2014111254A1 Composition of tiacumicin compounds |
| 07/24/2014 | WO2014057432A3 Multicomponent lipid nanoparticles and processes for the preparation thereof |
| 07/24/2014 | WO2012145460A3 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents |
| 07/24/2014 | US20140208464 Delivery of viral agents |
| 07/24/2014 | US20140207126 Bioconjugated nanoparticles |
| 07/24/2014 | US20140206903 Novelcrosslinking reagents, macromolecules, therapeutic conjugates, and synthetic methods thereof |
| 07/24/2014 | US20140206774 Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| 07/24/2014 | US20140206771 Liquid pharmaceutical composition comprising nitisinone |
| 07/24/2014 | US20140206766 Prostaglandin compositions and methods for the treatment of vasospasm |
| 07/24/2014 | US20140206765 Acetylcysteine Compositions and Methods of use Thereof |
| 07/24/2014 | US20140206759 Process for the production of biodegradeable, functionalised polymer particles, and use thereof as pharmaceutical supports |
| 07/24/2014 | US20140206733 Liquid Formulations Of Bendamustine |
| 07/24/2014 | US20140206717 Use of inorganic matrix and organic polymer combinations for preparing stable amorphous dispersions |
| 07/24/2014 | US20140206708 Composition for ophthalmic administration |
| 07/24/2014 | US20140206704 Starch-based microparticles for the release of agents disposed therein |
| 07/24/2014 | US20140206644 Methods and compositions for inhibiting cellular proliferation and surgical adhesion |
| 07/24/2014 | US20140206643 Pre-mixed, ready-to-use iv bolus nicardipine compositions and methods of use |
| 07/24/2014 | US20140206638 Pulmonary delivery of aminoglycoside |
| 07/24/2014 | US20140206635 Metal-salen complex compound, local anesthetic and antineoplastic drug |
| 07/24/2014 | US20140206626 Methods of providing therapeutic effects using cyclosporin components |
| 07/24/2014 | US20140206616 Sustained-Release Lipid Pre-Concentrate of Pharmacologically Active Substance And Pharmaceutical Composition Comprising The Same |
| 07/24/2014 | US20140206610 Preparation Comprising Insulin, Nicotinamide and an Amino Acid |
| 07/24/2014 | US20140206607 Glucagon/glp-1 receptor co-agonists |
| 07/24/2014 | US20140206602 Bipartite inhibitors of bacterial rna polymerase |
| 07/24/2014 | US20140206597 Opioid Prodrugs with Heterocyclic Linkers |
| 07/24/2014 | US20140206596 Design of pH-Sensitive Oligopeptide Complexes For Drug Release Under Mildly Acidic Conditions |
| 07/24/2014 | US20140206534 Formulation |
| 07/24/2014 | US20140206061 Bioactive carbon nanotube composite functionalized with b-sheet polypeptide block copolymer, and preparation method thereof |
| 07/24/2014 | US20140205676 Method of tissue repair using a composite material |
| 07/24/2014 | US20140205670 Stable solid preparations |
| 07/24/2014 | US20140205668 Surface modified proteinaceous spherical particles and uses thereof |
| 07/24/2014 | US20140205665 Bioresorbable microparticles |
| 07/24/2014 | US20140205663 Direct Compression Formulation and Process |
| 07/24/2014 | US20140205661 Formulation for retinoid-containing soft gelatin capsules |
| 07/24/2014 | US20140205657 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 07/24/2014 | US20140205651 Hygiene tissue |
| 07/24/2014 | US20140205638 Bab-type tri-block copolymer comprising polylactic acid (a) and polyethylene glycol (b), method for producing same, and drug delivery system using same |
| 07/24/2014 | US20140205616 Compositions and methods for the diagnosis and treatment of tumor |
| 07/24/2014 | US20140205599 Polypeptide that binds aberrant cells and induces apoptosis |
| 07/24/2014 | US20140205594 Treatment of cancer |
| 07/24/2014 | US20140205559 Antifungal compositions for the treatment of skin and nails |
| 07/24/2014 | US20140205545 Multivalent constructs for therapeutic and diagnostic applications |
| 07/24/2014 | US20140205544 Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine |
| 07/24/2014 | US20140205539 Dual Acting Prodrugs |
| 07/24/2014 | US20140202359 Rapid Setting High Strength Calcium Phosphate Cements Comprising Cyclodextrins |
| 07/23/2014 | EP2756852A1 Heparin-lipidic nanoparticle conjugates |
| 07/23/2014 | EP2756851A1 Product to assist with the ingestion of a solid compound |
| 07/23/2014 | EP2756840A1 Pharmaceutical composition for inhalation |
| 07/23/2014 | EP2756839A1 Composition in the form of a seawater gel, especially for use in massage |
| 07/23/2014 | EP2755692A1 Nanoconjugates able to cross the blood-brain barrier |
| 07/23/2014 | EP2755691A1 Hydrogels with biodegradable crosslinking |
| 07/23/2014 | EP2755690A1 Kisspeptide-pentasaccharide conjugates |
| 07/23/2014 | EP2755643A1 Compositions of jasmonate compounds and methods of use |
| 07/23/2014 | EP2755636A1 Amphiphilic cationic polymers for the delivery of therapeutic agents |
| 07/23/2014 | EP2755633A1 Method of coating microneedle devices |
| 07/23/2014 | EP2755632A1 A fast dissolving pharmaceutical composition |
| 07/23/2014 | EP2755630A2 Dermal filler compositions for fine line treatment |
| 07/23/2014 | EP2755623A1 Smarttm solid oral dosage forms |
| 07/23/2014 | CN203724485U 一种药物载体 A pharmaceutical carrier |
| 07/23/2014 | CN203724483U 一种胃滞留型渗透泵控释片 One kind of gastric retentive osmotic pump tablets |
| 07/23/2014 | CN1638751B 叶酸盐在制备用于预防和治疗炎症和炎症相关性疾病的药物制剂中的用途 Folate in the manufacture of pharmaceutical preparations for the prevention and treatment of inflammation and inflammation-related diseases in the use of |
| 07/23/2014 | CN103946234A 附加糖链的多肽和含有该多肽的医药组合物 Polypeptides and pharmaceutical compositions containing the oligosaccharide chain polypeptide |
| 07/23/2014 | CN103945902A 地西他滨衍生物制剂 Decitabine derivative formulation |
| 07/23/2014 | CN103945871A 用于治疗代谢疾病的融合蛋白 For the treatment of metabolic diseases of the fusion protein |
| 07/23/2014 | CN103945870A 生物可降解交联的水凝胶 Biodegradable cross-linked hydrogels |
| 07/23/2014 | CN103945869A 使用h-膦酸酯-烯/-炔的氢膦酸酯化反应进行的靶向纳米颗粒的远程组装 Remote assembly alkynyl hydrogen phosphonate reaction is targeted nanoparticle - Use h- phosphonate - ene / |
| 07/23/2014 | CN103945865A 用于将蛋白质递送至眼睛的缓释制剂及其制备方法 Protein delivery to the eye for a sustained release preparation and preparation method |
| 07/23/2014 | CN103945837A 含类胡萝卜素组合物及其制造方法 Carotenoid-containing composition and a method for manufacturing |
| 07/23/2014 | CN103937037A 用于制备空心胶囊的变性淀粉胶及其淀粉基质空心胶囊 For the preparation of hollow capsules of starch and starch gel matrix hollow capsules |
| 07/23/2014 | CN103936981A 一种类糖肽及其制备方法、可注射性水凝胶 One kind of class glycopeptides and preparation method, injectable hydrogel |
| 07/23/2014 | CN103936979A 一种聚(谷氨酸-co-乳酸)-磷脂酰乙醇胺接枝聚合物及其制备方法和应用 One poly (glutamic acid -co- lactic acid) - phosphatidylethanolamine graft polymer and its preparation method and application |
| 07/23/2014 | CN103936973A 一种多官能团聚环氧乙烷-b-脂肪族聚酯嵌段共聚物及其制备方法与应用 A multi-functional reunion oxide -b- aliphatic polyester block copolymer and its preparation method and application |
| 07/23/2014 | CN103936945A 一类新型高效抗肿瘤靶向药物载体及其制备方法 A new class of highly active anti-tumor targeting drug carrier and its preparation method |
| 07/23/2014 | CN103936883A 含巯基壳聚糖衍生物及复合物纳米粒子及制备方法 Thiol-containing chitosan derivatives and composite nanoparticles and preparation methods |
| 07/23/2014 | CN103936880A 纳米级颗粒型辅料 Nano-particle type accessories |
| 07/23/2014 | CN103936859A 人源化l243抗体 Humanized antibody l243 |
| 07/23/2014 | CN103936847A Peg-sa及其药物组合物 Peg-sa and pharmaceutical compositions |
| 07/23/2014 | CN103936829A 多肽和靶向药物载体及制备方法以及药物组合物及其制备方法 Peptides and targeted drug carriers and preparation methods and pharmaceutical compositions and preparation method |
| 07/23/2014 | CN103936826A 光敏性超分子水凝胶成胶因子及其制备方法和应用 Photosensitivity supramolecular hydrogels into the glue factor and its preparation method and application |
| 07/23/2014 | CN103936758A 一种生物素标记的川芎嗪及其制备方法 TMP and its preparation method biotinylated |
| 07/23/2014 | CN103936003A 多孔碳材料及其制备方法以及吸附剂、防护罩、吸附片和载体 Porous carbon material and preparation method and adsorbents, shields, adsorbing sheet and the carrier |
| 07/23/2014 | CN103933619A 神经修复材料及其制备方法 Nerve repair material and preparation method |
| 07/23/2014 | CN103933583A 抑制mgc-803细胞的手型金纳米团簇的制备及其用途 Preparation mgc-803 cells suppress hand-type gold clusters and their use |